Medical innovation has provided powerful tools to address one of the world’s most pressing health challenges. But the path to lasting wellness still requires ... Mar 07
The debate between pharmacotherapy and surgery will continue, but patients deserve nuanced guidance grounded in evidence, not trends... Feb 26
The obesity epidemic is vast. The solutions are emerging. Science is evolving. And the market is expanding. The launch of Yurpeak is another step in ... Dec 12
As more women use these medications globally and as research expands, the world will gain a clearer picture of how these powerful drugs shape reproductive ... Nov 26
As the patent clock ticks towards 2026, both Novo and Lilly are likely to intensify their efforts in expanding supply chains, boosting physician engagement, and ... Nov 14
Long-term effects of GLP-1 medications remain under investigation, and shifting to easy-to-use pens removes barriers but not risks.... Aug 16
Generic semaglutide could ultimately become not just an alternative, but the new standard driven by precision manufacturing, scaled access, and cost redefined.... Aug 11
Mounjaro met the primary objective of non-inferiority vs. Trulicity with an 8% lower rate of MACE-3 events, while delivering greater reductions in A1C ... Aug 01
India is stepping into a new phase of healthcare where the battle against obesity is no longer limited to gym memberships or diet fads.... Aug 01
As India confronts an alarming rise in obesity and related conditions like type 2 diabetes, cardiovascular disease, and polycystic ovarian syndrome, the spotlight on medical ... Jun 25
... May 12
A somewhat promising era of weight management has arrived. Ozempic and Mounjaro are no longer just for diabetes. But it’s not all magic. Risks, ... May 10
... Mar 20
Ozempic is not officially available in India and is not approved for use in India. While the demand for Ozempic is high, the supply is ... Jan 23
In response to the market demand, Indian drugmakers, including Cipla, are actively developing generic versions of these weight-loss drugs to secure a larger market ... May 13
Biocon's foray into the weight-loss drug market aligns with its significant investment in generics research and development, with a notable focus on peptides ... Apr 20
As the medication becomes available, its impact on individuals suffering from obesity and related conditions is eagerly anticipated. However, the pricing challenges highlight the need ... Nov 17
-Advertisements-
.jpeg)
Wednesday, October 07, 2026
.jpeg)
.jpeg)
.jpeg)
.jpeg)
.jpeg)
.jpeg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
